Abstract:Introduction: Acute rejection is an important cause of renal allograft loss. There is an urgent need to find an atraumatic marker that can be used alone or in combination with other indicators to make an early diagnosis of acute rejection, so that anti-rejection treatment can be performed in time before renal tissue damage occurs, which protects the function of the graft and enables the graft to survive for a long time. In the present study, we tried to further establish an early warning model of acute rejection by combining the three indicators of HLA-G 14-bp genotyping test, serum KIM-1 on the first postoperative day and serum OPN on the seventh postoperative day. Methods: We conducted a single-center study of 77 subjects, who were classified into acute rejection group (AR, n=32) and stable allograft function group (STA, n=45).All kidney transplant recipients received 2 ml of EDTA anticoagulated peripheral venous blood before kidney transplantation, and performed HLA-G 14-bp gene polymorphism typing. Serum KIM-1 level on the first postoperative day and OPN level on the 7th postoperative day were measured by Luminex. The study was approved by the local ethical committee. All patients with end-stage renal disease underwent kidney transplantation with living-related donor. The HLA-G+14/+14-bp genotype was significantly associated with acute rejection after transplantation. Therefore, we define recipients of the HLA-G+14/+14-bp genotype as positive, while HLA-G+14/−14-bp genotype and HLA-G−14/−14-bp genotype recipients are defined as negative. Serum KIM-1 on the first postoperative day was defined as positive if greater than 153 pg/ml and negative as less than 153 pg/ml; Serum OPN on the seventh postoperative day was defined as positive and less than 21921 pg/ml Defined as negative. Results: We have established three early warning models for acute rejection (Table 1)and found that Model 2 is the model with two or more positive diagnostic indicators. The ability to early alert acute rejection is the strongest, and the Youden index is the largest (0.75). The specificity was 84.38% and 91.11%, the positive predictive value and negative predictive value were 87.10% and 89.13%, respectively, and the average occurrence of acute rejection could be warned 6.44±6.12 days in advance (Table 2).The ability of Model 2 to early alert acute rejection is stronger than the other two models, becoming the best model for early warning of acute rejection in this study. Conclusions: We combined the HLA-G 14-bp genotyping test, serum KIM-1 on the first postoperative day, and OPN on the seventh postoperative day to establish three early warning models for acute rejection. Among the three models, the sensitivity and specificity of two or more positive indicators for early warning of acute rejection were 84.38% and 91.11%, which could predict the occurrence of acute rejection in advance.

Urine protein profiling identified alpha-1-microglobulin and haptoglobin as biomarkers for early diagnosis of acute allograft rejection following kidney transplantation

Non-invasive detection of acute renal allograft rejection by measurement of vascular endothelial growth factor in urine.

Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.

Artificial Urinary Biomarkers for Early Diagnosis of Acute Renal Allograft Rejection

Diagnosis of C4d+ Renal Allograft Acute Humoral Rejection by Urine Protein Fingerprint Analysis.

Characterization of Acute Renal Allograft Rejection by Human Serum Proteomic Analysis.

Acute Renal Allograft Rejection is Associated with Increased Levels of Vascular Endothelial Growth Factor in the Urine

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

Urine proteomics in kidney transplantation

Non-Invasive Diagnosis for Acute Rejection Using Urinary mRNA Signature Reflecting Allograft Status in Kidney Transplantation

Detection of renal allograft dysfunction with characteristic protein fingerprint by serum proteomic analysis

Screening of novel biomarkers for acute kidney transplant rejection using DIA‐MS based proteomics

Prediction of Acute Renal Allograft Rejection by Combined HLA-G 14-Bp Insertion/deletion Genotype Analysis and Detection of Kidney Injury Molecule-1 and Osteopontin in the Peripheral Blood.

Proteomic Analysis of Acute Kidney Allograft Rejection in Rat

GC/MS-based Urine Metabolomics Analysis of Renal Allograft Recipients with Acute Rejection

Assessment of Different Biomarkers Provides Valuable Diagnostic Standards in the Evaluation of the Risk of Acute Rejection.

ESTABLISHMENT OF EARLY WARNING MODEL OF ACUTE REJECTION IN COMBINATION WITH HLA-G 14-BP GENE POLYMORPHISM, SERUM KIM-1AND OPN

[Noninvasive Diagnostic and Predictive Value in Renal Transplant Recipients with Acute Rejection by Measurement of Urine Fractalkine].

Diagnosis of Renal Allograft Subclinical Rejection by Urine Protein Fingerprint Analysis.

Urine CXCL10 as a biomarker in kidney transplantation

A Pilot Study of GC/MS-based Serum Metabolic Profiling of Acute Rejection in Renal Transplantation